| Authors: |
Hiippala K; Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Barreto G; Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Burrello C; Department of Experimental Oncology, European Institute of Oncology, Milan, Italy., Diaz-Basabe A; Department of Experimental Oncology, European Institute of Oncology, Milan, Italy., Suutarinen M; Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Kainulainen V; Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Bowers JR; Translational Genomics Research Institute, Pathogen and Microbiome Division, Flagstaff, Arizona, AZ, United States., Lemmer D; Translational Genomics Research Institute, Pathogen and Microbiome Division, Flagstaff, Arizona, AZ, United States., Engelthaler DM; Translational Genomics Research Institute, Pathogen and Microbiome Division, Flagstaff, Arizona, AZ, United States., Eklund KK; Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Helsinki University and Helsinki University Hospital, Department of Rheumatology, Helsinki, Finland and ORTON Orthopedic Hospital of the Orton Foundation, Helsinki, Finland., Facciotti F; Department of Experimental Oncology, European Institute of Oncology, Milan, Italy., Satokari R; Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland. |
